From: Microbial involvement in Alzheimer disease development and progression
Finding | Supported by | Model |
---|---|---|
Amyloid as AMP | 19, 20 | 5XFAD mouse [19], in vitro [19, 20], nematode [19], human brain tissue [20] |
Bacteria colocalizes with Aβ plaques | 21, 40 | Sprague-Dawley rats [21], Human brain tissue [40], specific pathogen-free BALB/c mice [40] |
Ab fibrils activate microglia | 45 | Human THP-1 monocytes and microglia |
EP2 induces neuronal damage by toxicity and increased amyloid beta levels | 49 | APPSWE-PS1â–³E9 mice |
Overactive microglia lead to neuroinflammation | 53 | APP/PS1 mice |
LPS is more abundant in AD brain | 99, 100 | Human brain tissue |
LPS stimulation leads to enhanced Aβ accumulation | 23, 24 | |
AD induces changes in bacterial communities | 25-29 | APP/PS1 mouse stool [25], human stool [26,27,28], human brain tissue [29] |
Broad-spectrum antibiotic cocktail altered gut bacterial communities and reduced AD hallmark characteristics | 89 | APPSWE/PS1ΔE9 mice |
Rifampicin treatment reduced AD hallmark characteristics | 30-33 | |
Minocycline treatment reduced AD hallmark characteristics | 34, 35 | |
Periodontal disease risk factor for AD | 112 | Human patient serum |
P. gingivalis can access brain and associate with Aβ plaques | 36-38, 40 | Human brain tissue [36, 40], ApoE−/− mice [37, 38], specific pathogen-free BALB/c mice [40] |
AD patients have increased antibodies to periodontal disease-associated microbes | 112, 114 | Human patient serum |
Probiotic supplementation improves cognitive function and reduces neuroinflammation | 102, 103 | Human |